As a result, single-cell transcriptome analysis revealed a clear difference in the expression level of a cancer biomarker gene (i.e., EpCAM) between different types of cancer cells (Kato III and MDA-MB-231 cells) at the single-cell level. The gene discussed is EPCAM; the disease is cancer.